Lassen Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$85M
- Investors
-
7
Lassen Therapeutics General Information
Description
Developer of antibody biotherapeutics intended to improve the lives of patients suffering from serious diseases. The company's biotherapeutics are developed by applying antibody technologies to create a pipeline of breakthrough therapeutics that play a key role in the tumor microenvironment of certain cancers, enabling health professionals to get access to therapeutics that target interleukin-one disease, a cytokine that is a central mediator of fibrosis.
Contact Information
Website
www.lassentherapeutics.comCorporate Office
- 5510 Morehouse Drive
- Suite 100
- San Diego, CA 92121
- United States
Corporate Office
- 5510 Morehouse Drive
- Suite 100
- San Diego, CA 92121
- United States
Lassen Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 19-Dec-2023 | $85M | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC (Series A) | 23-Aug-2019 | Completed | Pre-Clinical Trials |
Lassen Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lassen Therapeutics Comparisons
Industry
Financing
Details
Lassen Therapeutics Competitors (3)
One of Lassen Therapeutics’s 3 competitors is Sling Therapeutics, a Venture Capital-Backed company based in Ann Arbor, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sling Therapeutics | Venture Capital-Backed | Ann Arbor, MI | ||||
| Viridian Therapeutics | Formerly VC-backed | Waltham, MA | ||||
| Pliant Therapeutics | Formerly VC-backed | San Francisco, CA |
Lassen Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lassen Therapeutics Patents
Lassen Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024148240-A1 | Anti-il-11rα antibodies for treating thyroid eye disease | Inactive | 06-Jan-2023 | ||
| WO-2024148241-A1 | Anti-il-18bp antibodies | Inactive | 06-Jan-2023 | ||
| WO-2024148243-A1 | Anti-il-18bp antibodies | Inactive | 06-Jan-2023 | ||
| CA-3230523-A1 | Anti-il-11r.alpha. antibodies | Pending | 30-Aug-2021 | ||
| WO-2023034809-A1 | Anti-il-11rα antibodies | Inactive | 30-Aug-2021 | C07K16/2866 |
Lassen Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lassen Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BVF Partners | Hedge Fund | Minority | ||
| Catalio Capital Management | Venture Capital | Minority | ||
| Longitude Capital | Venture Capital | Minority | ||
| Alta Partners | Venture Capital | Minority | ||
| DC Investment Partners | Venture Capital | Minority |
Lassen Therapeutics FAQs
-
When was Lassen Therapeutics founded?
Lassen Therapeutics was founded in 2019.
-
Where is Lassen Therapeutics headquartered?
Lassen Therapeutics is headquartered in San Diego, CA.
-
What is the size of Lassen Therapeutics?
Lassen Therapeutics has 24 total employees.
-
What industry is Lassen Therapeutics in?
Lassen Therapeutics’s primary industry is Drug Discovery.
-
Is Lassen Therapeutics a private or public company?
Lassen Therapeutics is a Private company.
-
What is Lassen Therapeutics’s current revenue?
The current revenue for Lassen Therapeutics is .
-
How much funding has Lassen Therapeutics raised over time?
Lassen Therapeutics has raised $117M.
-
Who are Lassen Therapeutics’s investors?
BVF Partners, Catalio Capital Management, Longitude Capital, Alta Partners, and DC Investment Partners are 5 of 7 investors who have invested in Lassen Therapeutics.
-
Who are Lassen Therapeutics’s competitors?
Sling Therapeutics, Viridian Therapeutics, and Pliant Therapeutics are competitors of Lassen Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
